Gum Grafting Market Growth Factors, Company Profile Analysis, Research Methodology and Forecast
The Gum Grafting Market is anticipated to reach USD 794.22 Million by 2030 at 8.10% CAGR during the forecast period 2022-2030.
The Gum Grafting Market has witnessed significant growth in recent years, driven by the increasing prevalence of gum recession and the growing awareness of oral health. Gum grafting, also known as gum transplant or gum replacement, is a surgical procedure that involves taking tissue from one part of the mouth and grafting it onto the receding gums. This procedure is crucial for addressing issues such as gum recession, which can lead to tooth sensitivity, aesthetic concerns, and even tooth loss if left untreated.
The demand for gum grafting procedures has risen as people become more conscious of their oral health and seek effective solutions to restore gum tissue. Factors such as aging, genetics, and poor oral hygiene contribute to gum recession, making gum grafting an essential intervention. The market is witnessing advancements in grafting techniques and materials, enhancing the efficacy and patient experience.
The gum grafting market is also driven by the increasing prevalence of periodontal diseases, which often result in gum recession. The rising adoption of cosmetic dentistry procedures to improve the aesthetics of the smile further contributes to the market's growth. As technology continues to play a vital role in dental procedures, the gum grafting market is poised for continuous expansion, providing innovative solutions for individuals seeking gum replacement and restoration.Top of Form
Major Key Players:
This Gum Grafting Companies are namely BioHorizons IPH, Inc (UK), Dr. Fresh LLC (US), Colgate-Palmolive Company (US), GlaxoSmithKline plc (UK), 3M Company (US), Ultradent Products Inc. (US), Sunstar Suisse S.A. (UK), and PatientPop.Inc (US).
Segment Analysis
The global gum grafting market is segmented on the basis of applications, types, end users and regions.
On the basis of applications, the market subsegments into root coverage, ridge augmentation, augmentation around implants, reduced sensitivity, improved appearance, gum health, and others.
On the basis of types, the market is classified into connective-tissue, subepithelial connective tissue graft, free gingival grafts, pedicle grafts, and Alloderm.
On the basis of end users, the market is categorized into dentists, hospitals, and others.
Regional Analysis
The global gum grafting market is dominated by America, owing to the presence of a huge number of patients here, who are suffering from dental problems and the huge geriatric population. According to the Centers for Disease Control and Prevention, one out of every two American adults aged 30 years and over, has periodontal disease. In addition to this, high healthcare spending and presence of some of the major players in this region, has also contributed to the growth of this market. Europe accounts for the second largest market, as people here are being encouraged for dental surgeries and the well-established healthcare sector. Asia Pacific is the fastest growing market, due to the presence of a number of growth opportunities here and continuously increasing demand. On the other hand, Middle East & Africa has the least market share.
The global gum grafting market is highly fragmented with the presence of many local and international players. Local players are focused on cost reduction and innovation to ensure sustainability. In addition, international players implemented growth strategies through collaborations and partnerships, to expand their overall market share.
BioHorizons IPH, Inc., headquartered in Birmingham, UK, is a manufacturer and supplier of introduced dental implant products’ covering, virtually every surgical and prosthetic indication or clinician preference. This company has launched Tapered Internal Implant, which was designed with a beveled collar for increased bone and soft tissue attachment and to provide benefits of platform switching. AlloDerm, Regenerative Tissue Matrix (RTM), is the most widely accepted and researched acellular dermal matrix for dental soft tissue applications.
For More Information, Please Visit @ Market Research Future
- Questions and Answers
- Opinion
- Story/Motivational/Inspiring
- Technology
- Art
- Causes
- Crafts
- Dance
- Drinks
- Film/Movie
- Fitness
- Food
- Games
- Gardening
- Health
- Home
- Literature
- Music
- Networking
- Other
- Party
- Religion
- Shopping
- Sports
- Theater
- Wellness
- News
- Culture
- War machines and policy